Home
About
Overview
Sharing Data
ORCID
Help
History (4)
Characterization of an ovarian cancer activating factor in ascites from ovarian cancer patients.
Prevention of chemotherapy-induced nausea and vomiting and the role of neurokinin 1 inhibitors: from guidelines to clinical practice in solid tumors.
Prevention of mammary carcinogenesis in MMTV-neu mice by targeting RLIP.
The EphB4 receptor tyrosine kinase promotes lung cancer growth: a potential novel therapeutic target.
See All 4 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Characterization of an ovarian cancer activating factor in ascites from ovarian cancer patients.
Characterization of an ovarian cancer activating factor in ascites from ovarian cancer patients. Clin Cancer Res. 1995 Oct; 1(10):1223-32.
View in:
PubMed
subject areas
Ascites
Calcium
Cell Division
Fatty Acids
Female
Growth Substances
Humans
Lysophospholipids
Mass Spectrometry
Neoplasm Proteins
Ovarian Neoplasms